Literature DB >> 10537967

Direct costs of hip fractures in patients over 60 years of age in Belgium.

J Y Reginster1, P Gillet, W Ben Sedrine, G Brands, O Ethgen, C de Froidmont, C Gosset.   

Abstract

OBJECTIVE: Osteoporosis-related costs are now considered a major burden for health authorities in most developed countries. An accurate and exhaustive evaluation of these costs would be a major contribution to health economic studies evaluating the efficiency of screening and prevention strategies. Osteoporosis is the most frequent underlying cause of femoral neck fractures in the elderly; these fractures weigh heavily on healthcare budgets. However, in Belgium, very few data on the financial burden of hip fractures are available and no updated estimates have been made. The goal of this paper is to estimate the direct medical expenditures associated with hip fractures in Belgium in 1996. DESIGN AND
SETTING: This 1-year population-based cross-sectional study is conducted from the social security perspective. The target population in this study are men and women aged 60 years and over. PATIENTS AND PARTICIPANTS: We selected patients who had been hospitalised for a hip fracture during the year 1996 who were also affiliated with a registered social security organisation (covering 25% of the Belgian population). The sample constituted 2374 patients.
INTERVENTIONS: For each of these patients, we collected an exhaustive and detailed list of healthcare resource use as well as nursing home admissions following the hip fracture event. Cost items investigated in the analysis were inpatient hospital costs and outpatient costs. Mean annual costs per case recorded in the sample were then extrapolated to the whole country on the basis of an exhaustive list of diagnoses having lead to all countrywide hospitalisations (1,700,000 hospital stays/year). MAIN OUTCOME MEASURES AND
RESULTS: The mean hospital inpatient costs for hip fracture were evaluated at 332,148 Belgian francs (BeF) [$US8977] per case and BeF4,367,746,200 ($US118,047,194) for the whole country (10 million inhabitants). Patients with a hip fracture experienced an annual BeF27,825 ($US752) extra outpatient cost during the year following this fracture event, after correcting for costs related to additional comorbidity already present before the hip fracture. Finally, after a proximal femoral neck fracture, the rate of nursing home admission was higher, both for men and women at any age compared with age- and gender-matched population.
CONCLUSIONS: With a total cost (acute hospital and outpatient costs) of BeF4,667,894,950 ($US126,159,323) per year in Belgium, proximal femoral neck fracture should be considered a major health economic problem and appropriate measures to prevent this disease should be rapidly undertaken.

Entities:  

Mesh:

Year:  1999        PMID: 10537967     DOI: 10.2165/00019053-199915050-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  18 in total

1.  Epidemiology and socioeconomic cost of osteoporotic fractures in Greece.

Authors:  G Lyritis
Journal:  Calcif Tissue Int       Date:  1992-08       Impact factor: 4.333

2.  Direct clinical and welfare costs of osteoporotic fractures in elderly men and women.

Authors:  A Randell; P N Sambrook; T V Nguyen; H Lapsley; G Jones; P J Kelly; J A Eisman
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

3.  Clinical outcomes and mortality after hip fracture: a 2-year follow-up study.

Authors:  C Baudoin; P Fardellone; K Bean; A Ostertag-Ezembe; F Hervy
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

4.  Increase in the incidence of hip fractures and of the ratio of trochanteric to cervical hip fractures in Belgium.

Authors:  C Nagant de Deuxchaisnes; J P Devogelaer
Journal:  Calcif Tissue Int       Date:  1988-03       Impact factor: 4.333

5.  Epidemiology and costs of osteoporotic hip fractures in Portugal.

Authors:  A L Vaz
Journal:  Bone       Date:  1993       Impact factor: 4.398

6.  A prospective study on socioeconomic aspects of fracture of the proximal femur.

Authors:  M A Schürch; R Rizzoli; B Mermillod; H Vasey; J P Michel; J P Bonjour
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

7.  Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland.

Authors:  K Lippuner; J von Overbeck; R Perrelet; H Bosshard; P Jaeger
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

8.  Consequences of a hip fracture: a prospective study over 1 year.

Authors:  I Sernbo; O Johnell
Journal:  Osteoporos Int       Date:  1993-05       Impact factor: 4.507

9.  Cost analysis of osteoporosis related to untreated menopause.

Authors:  E Levy
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

Review 10.  Hip fractures: a worldwide problem today and tomorrow.

Authors:  L J Melton
Journal:  Bone       Date:  1993       Impact factor: 4.398

View more
  24 in total

1.  Economic cost of the treatment of fractures among old people: a preliminary study in dakar teaching hospital.

Authors:  Charles Bertin Diémé
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-09

Review 2.  The association between metabolic syndrome and bone mineral density: a meta-analysis.

Authors:  Peng Xue; Ping Gao; Yukun Li
Journal:  Endocrine       Date:  2012-05-01       Impact factor: 3.633

3.  Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database.

Authors:  Milka Maravic; Christine Le Bihan; Paul Landais; Patrice Fardellone
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

Review 4.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  The direct and indirect costs of the chronic management of osteoporosis: a prospective follow-up of 3440 active subjects.

Authors:  V Rabenda; C Manette; R Lemmens; A-M Mariani; N Struvay; J-Y Reginster
Journal:  Osteoporos Int       Date:  2006-06-24       Impact factor: 4.507

Review 6.  Hip fracture prevention: cost-effective strategies.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  Costs and quality of life associated with osteoporosis-related fractures in Sweden.

Authors:  Fredrik Borgström; Niklas Zethraeus; Olof Johnell; Lars Lidgren; Sari Ponzer; Olle Svensson; Peter Abdon; Ewald Ornstein; Karl Lunsjö; Karl Göran Thorngren; Ingemar Sernbo; Clas Rehnberg; Bengt Jönsson
Journal:  Osteoporos Int       Date:  2005-11-09       Impact factor: 4.507

8.  Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.

Authors:  M Hiligsmann; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-04-07       Impact factor: 4.507

9.  Cost of stress urinary incontinence: a claims data analysis.

Authors:  Howard G Birnbaum; Stephanie A Leong; Emily F Oster; Kraig Kinchen; Peter Sun
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: a Pharmo study.

Authors:  Martien J M Panneman; Wim G Goettsch; Piotr Kramarz; Ron M C Herings
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.